Obstetrical Antiphospholipid Syndrome: From the Pathogenesis to the Clinical and Therapeutic Implications
Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations associated with the presence of antiphospholipid antibodies (aPL) in patient plasma. Obstetrical APS is a complex entity that may affect both mother and fetus throughout the entire pregnancy with high morbidity...
Main Authors: | T. Marchetti, M. Cohen, P. de Moerloose |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/159124 |
Similar Items
-
Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
by: Zhuochao Zhou, et al.
Published: (2021-08-01) -
Catastrophic antiphospholipid syndrome in obstetric practice
by: Валерий Николаевич Запорожан, et al.
Published: (2015-05-01) -
The use of bemiparin in obstetric antiphospholipid syndrome
by: N K Tetruashvili, et al.
Published: (2015-06-01) -
On the pathogenesis of thromboses in antiphospholipid syndrome
by: T. A. Sukontseva, et al.
Published: (2018-11-01) -
Obstetric antiphospholipid syndrome: An approach from glycans of the immunoglobulin G
by: Angela Maria Alvarez, et al.
Published: (2021-01-01)